Rezulin: Diabetes Drug

Rezulin® Online is an Internet resource designed to help people who may suffer from liver damage due the use of the diabetes drug Rezulin. Look to this site for the newest research, diagnosis information, legal resources and treatment options for patients who have used Rezulin.

Are you...

If you answered "yes" to any of these questions, it's important that you explore this site further and find out more about your options.

Rezulin News Timeline

January Rezulin is approved by the FDA to treat Type II diabetes.
November The FDA issues a warning about Rezulin (troglitazone). Recommended prescribing information is changed by the drug's manufacturer; new warning label information is added.
December Approximately 150 adverse events associated with Rezulin have been reported to the FDA.
June The FDA and Rezulin manufacturer Parke-Davis agree to again tighten restrictions on the use of Rezulin.
July Parke-Davis sends a letter to heathcare professionals warning to test for liver abnormalities and updating them on the changes in recommended use.
March Resulin sales are discontinued.

Last update: November 30, 2016. 09:40:06 am.